We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,460 results
  1. An Acute Need Inspiration: Autoneutralization of Lupus Anticoagulants in Affected Prothrombin Times (PT) and Activated Partial Thromboplastin Times (APTT)

    Lupus anticoagulants are antibodies directed to phospholipids (PL) and in particular represent an in vitro phenomenon where these antibodies bind to...
    Robert C. Gosselin in Hemostasis and Thrombosis
    Protocol 2023
  2. Performance and Interpretation of Clot Waveform Analysis

    The prothrombin time (PT) and the activated partial thromboplastin time (aPTT) are two basic tests for routine purposes, which are widely used in the...
    Maria Filomena Ruberto, Francesco Marongiu, Doris Barcellona in Hemostasis and Thrombosis
    Protocol 2023
  3. Head-to-head ex vivo comparison of clinically used direct anticoagulant drugs

    An imbalance in coagulation is associated with cardiovascular events. For prevention and treatment, anticoagulants, currently mainly xabans and...

    Jaka Fadraersada, Raúl Alva-Gallegos, ... Přemysl Mladěnka in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 19 December 2023
  4. An Overview of Heparin Monitoring with the Anti-Xa Assay

    Heparin remains a critical therapy in hospitalized patients requiring anticoagulation. Unfractionated heparin (UFH) mediates its therapeutic effect...
    Christina L. Dean in Hemostasis and Thrombosis
    Protocol 2023
  5. Analysis of clinical characteristics and risk factors for death due to severe influenza in children

    Objective

    The study analyzed the clinical features of children who had severe influenza and discussed on the risk factors associated with death in...

    Ruiyang Sun, Xue Zhang, ... Chunlan Song in European Journal of Clinical Microbiology & Infectious Diseases
    Article 19 January 2024
  6. Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors

    The regimens for factor Xa (FXa) inhibitors (apixaban, edoxaban, and rivaroxaban) vary with venous thromboembolism (VTE) or non-valvular atrial...

    Ryohei Ono, Kazutaka Nishimura, ... Yoshio Kobayashi in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 03 November 2022
  7. Auto-validation of Routine Coagulation/Hemostasis Assays with Reflex Testing of Abnormal Test Results

    Hemostasis laboratories play a crucial role in the diagnosis and treatment of individuals with bleeding or thrombotic disorders. Routine coagulation...
    Emmanuel J. Favaloro, Soma Mohammed, ... Leonardo Pasalic in Hemostasis and Thrombosis
    Protocol 2023
  8. Assays to Monitor Bivalirudin

    Bivalirudin (Angiomax, Angiox) is a parenteral direct thrombin inhibitor (DTI) that is used for patients with heparin-induced thrombocytopenia (HIT),...
    Simon Davidson in Hemostasis and Thrombosis
    Protocol 2023
  9. The value of plasma presepsin as a diagnostic and prognostic biomarker for sepsis in Southern China

    Background

    Presepsin is a soluble CD14 subtype that has been considered as a novel marker for patients with sepsis. This study explored the clinical...

    Juehui Wu, **aoxia Zhan, ... **mei Luo in Inflammation Research
    Article 05 September 2023
  10. The prognostic role of coagulation markers in the progression and metastasis of laryngeal squamous cell carcinoma

    Background

    The application of coagulation-related markers in laryngeal squamous cell carcinoma(LSCC) remains unclear. This study explored the...

    Qiongling Huang, **g Chen, ... Chaohui Zheng in BMC Cancer
    Article Open access 25 September 2023
  11. Analysis of risk factors associated with fatal outcome among severe fever with thrombocytopenia syndrome patients from 2015 to 2019 in Shandong, China

    To better understand the progression of severe fever with thrombocytopenia syndrome (SFTS), identify early predictors of mortality, and improve the...

    Li Song, Yingjie Zhao, ... Lintao Sai in European Journal of Clinical Microbiology & Infectious Diseases
    Article 11 October 2022
  12. Coagulation markers in patients with venous thromboembolism treated with 10 mg apixaban twice daily

    Abstract

    Apixaban is used to treat venous thromboembolism (VTE) at 10 mg twice daily (BID) for 7 days, followed by 5 mg BID without dose adjustment,...

    Ryohei Ono, Kenichi Fukushima, ... Kazutaka Nishimura in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 01 December 2021
  13. Safety and Pharmacokinetics of Intranasally Administered Heparin

    Purpose

    Intranasally administered unfractionated heparin (UFH) and other sulfated polysaccharides are potential prophylactics for COVID-19. The...

    Hannah M. Harris, Katherine L. Boyet, ... Joshua S. Sharp in Pharmaceutical Research
    Article 02 March 2022
  14. Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer

    Background

    In recent years, multiple coagulation and fibrinolysis (CF) indexes have been reported to be significantly related to the progression and...

    Peng Yunpeng, Yin Lingdi, ... Li Qiang in BMC Cancer
    Article Open access 15 June 2023
  15. Ethacrynic acid is an inhibitor of human factor XIIIa

    Background

    Ethacrynic acid (EA) is a loop diuretic that is approved orally and parenterally to manage edema-associated diseases. Nevertheless, it was...

    Srabani Kar, Kayla Vu, ... Rami A. Al-Horani in BMC Pharmacology and Toxicology
    Article Open access 01 June 2022
  16. Mutation Analysis of F11 Gene in Patients with FXI Deficiency in Russia

    Abstract

    Factor FXI is an essential participant of the blood coagulation cascade and is coded by the F11 gene, mutations in which lead to an...

    O. S. Pshenichnikova, V. L. Surin, ... N. I. Zozulya in Russian Journal of Genetics
    Article 12 July 2022
  17. Phloretin targets SIRT1 to alleviate oxidative stress, apoptosis, and inflammation in deep venous thrombosis

    Deep vein thrombosis (DVT) is a type of venous thromboembolism posing a serious threat to health on a global scale. Phloretin is a potential natural...

    **aodong Wang, ** Yan, ... Yin Ying in Toxicological Research
    Article 30 August 2023
  18. Clinical characteristics and risk factor analysis of Pneumocystis jirovecii pneumonia in patients with CKD: a machine learning–based approach

    Patients with chronic kidney disease (CKD) who are being treated with immunosuppressive medications are at risk for develo** Pneumocystis jirovecii ...

    **ao-Yu Cai, Yi-Chun Cheng, ... Gang Xu in European Journal of Clinical Microbiology & Infectious Diseases
    Article 01 February 2023
  19. Effect of low-molecular-weight heparin calcium combined with magnesium sulfate and labetalol on coagulation, vascular endothelial function and pregnancy outcome in early-onset severe preeclampsia

    Objective

    This paper was aimed at unveiling the effect of low-molecular-weight heparin calcium (LMWH) combined with magnesium sulfate and labetalol on...

    Yang Liu, Miao Zhou, ... **g Du in European Journal of Clinical Pharmacology
    Article 21 June 2024
  20. Development of Laboratory Parameters-Based Formulas in Predicting Short Outcomes for Adult Hemophagocytic Lymphohistiocytosis Patients with Different Underlying Diseases

    Purpose

    Hemophagocytic lymphohistiocytosis (HLH) is a severe disease with high mortality. The purpose of this investigation was to build models to...

    Jun Zhou, Zhi-Qi Wu, ... Hua-Guo Xu in Journal of Clinical Immunology
    Article 06 April 2022
Did you find what you were looking for? Share feedback.